Lauer, Arne
Speroni, Samantha L.
Choi, Myoung http://orcid.org/0000-0001-8389-3921
Da, Xiao
Duncan, Christine
McCarthy, Siobhan
Krishnan, Vijai
Lusk, Cole A.
Rohde, David http://orcid.org/0000-0002-3785-9375
Hansen, Mikkel Bo http://orcid.org/0000-0002-8619-1519
Kalpathy-Cramer, Jayashree http://orcid.org/0000-0001-8906-9618
Loes, Daniel J.
Caruso, Paul A.
Williams, David A.
Mouridsen, Kim
Emblem, Kyrre E.
Eichler, Florian S.
Musolino, Patricia L. http://orcid.org/0000-0001-8724-5649
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (K08 NS094683-01)
Article History
Received: 25 September 2020
Accepted: 7 March 2023
First Online: 5 April 2023
Competing interests
: This work was funded primarily by NINDS K08 NS094683-01 and R01NS117575 with a partial contribution from Bluebird Bio. D.J.L. is a consultant for Bluebird Bio. D.W. has received research funding for research in hemoglobinopathies and licensed certain IP relevant to hemoglobinopathies to Bluebird Bio. He has received payments from Bluebird Bio in past through BCH institutional licensing agreement and has the potential for future royalty/milestone income. P.L.M. is the co-I of Bluebird Bio clinical trials. She is a consultant to bluebird bio. F.S.E. is the co-PI of Bluebird Bio clinical trials. M.B.H and K.M. are co-applicants on a patent application based on the presented techniques in this manuscript (PCT/DK2014/050296) and are shareholders in Cercare Medical ApS. A.L.; S.L.S.; M.C.; X.D.; C.D.; S.M.C.; V.K.; C.A.L.; D.R.; J.K.-C.; K.E., and P.C. do not have any disclosures to report directly relating to this study.